Cargando…

Multiplicity of Advanced T Category–Tumors Is a Risk Factor for Survival in Patients with Colorectal Carcinoma

BACKGROUND: Previous studies on synchronous colorectal carcinoma (SCRC) have reported inconsistent results about its clinicopathologic and molecular features and prognostic significance. METHODS: Forty-six patients with multiple advanced tumors (T2 or higher category) who did not receive neoadjuvant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Hye Eun, Yoo, Seungyeon, Bae, Jeong Mo, Jeong, Seorin, Cho, Nam-Yun, Kang, Gyeong Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Pathologists and the Korean Society for Cytopathology 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250932/ https://www.ncbi.nlm.nih.gov/pubmed/30458607 http://dx.doi.org/10.4132/jptm.2018.10.02

Ejemplares similares

Improved results of LINE-1 methylation analysis in formalin-fixed, paraffin-embedded tissues with the application of a heating step during the DNA extraction process
por: Wen, Xianyu, et al.
Publicado: (2017)

p53 expression status is associated with cancer-specific survival in stage III and high-risk stage II colorectal cancer patients treated with oxaliplatin-based adjuvant chemotherapy
por: Oh, Hyeon Jeong, et al.
Publicado: (2019)

Tumoral LINE-1 hypomethylation is associated with poor survival of patients with intrahepatic cholangiocarcinoma
por: Jeong, Seorin, et al.
Publicado: (2017)

CpG Island Methylation in Sessile Serrated Adenoma/Polyp of the Colorectum: Implications for Differential Diagnosis of Molecularly High-Risk Lesions among Non-dysplastic Sessile Serrated Adenomas/Polyps
por: Lee, Ji Ae, et al.
Publicado: (2019)

Clinicopathological Characterization and Prognostic Implication of SMAD4 Expression in Colorectal Carcinoma
por: Yoo, Seung-Yeon, et al.
Publicado: (2019)

Clinicopathologic, molecular, and prognostic implications of the loss of EPCAM expression in colorectal carcinoma
por: Kim, Jung Ho, et al.
Publicado: (2015)

Image Analyzer-Based Assessment of Tumor-Infiltrating T Cell Subsets and Their Prognostic Values in Colorectal Carcinomas
por: Kim, Younghoon, et al.
Publicado: (2015)

Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway
por: Kim, Jung Ho, et al.
Publicado: (2016)

A comparative prognostic performance of definitions of Crohn-like lymphoid reaction in colorectal carcinoma
por: Kim, Younghoon, et al.
Publicado: (2021)

Assessment of copy number in protooncogenes are predictive of poor survival in advanced gastric cancer
por: Li, Meihui, et al.
Publicado: (2021)

Tumor microenvironment-adjusted prognostic implications of the KRAS mutation subtype in patients with stage III colorectal cancer treated with adjuvant FOLFOX
por: Park, Hye Eun, et al.
Publicado: (2021)

Overexpression of POSTN in Tumor Stroma Is a Poor Prognostic Indicator of Colorectal Cancer
por: Oh, Hyeon Jeong, et al.
Publicado: (2017)

Immune landscape and biomarkers for immuno-oncology in colorectal cancers
por: Bae, Jeong Mo, et al.
Publicado: (2020)

Fibroblast Growth Factor Receptor 1 (FGFR1) Amplification Detected by Droplet Digital Polymerase Chain Reaction (ddPCR) Is a Prognostic Factor in Colorectal Cancers
por: Bae, Jeong Mo, et al.
Publicado: (2020)

Differential Features of Microsatellite-Unstable Colorectal Carcinomas Depending on EPCAM Expression Status
por: Kim, Jung Ho, et al.
Publicado: (2014)

Targeted next-generation sequencing-based detection of microsatellite instability in colorectal carcinomas
por: Lee, Yunbeom, et al.
Publicado: (2021)

Prognostic Impact of Fusobacterium nucleatum Depends on Combined Tumor Location and Microsatellite Instability Status in Stage II/III Colorectal Cancers Treated with Adjuvant Chemotherapy
por: Oh, Hyeon Jeong, et al.
Publicado: (2019)

SMOC2, an intestinal stem cell marker, is an independent prognostic marker associated with better survival in colorectal cancers
por: Jang, Bo Gun, et al.
Publicado: (2020)

Genomic and transcriptomic characterization of heterogeneous immune subgroups of microsatellite instability-high colorectal cancers
por: Kim, Jung Ho, et al.
Publicado: (2021)

Pathologic Factors Associated with Prognosis after Adjuvant Chemotherapy in Stage II/III Microsatellite-Unstable Colorectal Cancers
por: Kim, Jung Ho, et al.
Publicado: (2015)

Prognostic Significance of EPHB2 Expression in Colorectal Cancer Progression
por: Jang, Bo Gun, et al.
Publicado: (2018)

Characterisation of PD-L1-positive subsets of microsatellite-unstable colorectal cancers
por: Kim, Jung Ho, et al.
Publicado: (2016)

Methylation statuses of NCOR2, PARK2, and ZSCAN12 signify densities of tumor-infiltrating lymphocytes in gastric carcinoma
por: Wen, Xianyu, et al.
Publicado: (2022)

Expression Profile and Prognostic Significance of EPHB3 in Colorectal Cancer
por: Jang, Bo Gun, et al.
Publicado: (2020)

Blood-Based Detection of Colorectal Cancer Using Cancer-Specific DNA Methylation Markers
por: Cho, Nam-Yun, et al.
Publicado: (2020)

Distribution and malignancy risk of six categories of the pathology reporting system for thyroid core-needle biopsy in 1,216 consecutive thyroid nodules
por: Son, Hye Min, et al.
Publicado: (2020)

Prognostic and clinicopathological significance of Fusobacterium nucleatum in colorectal cancer: a systemic review and meta-analysis
por: Kim, Younghoon, et al.
Publicado: (2022)

Repeat Diagnoses of Bethesda Category III Thyroid Nodules: What To Do Next?
por: Yoo, Mi Ri, et al.
Publicado: (2015)

Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system
por: Bae, Jeong Mo, et al.
Publicado: (2017)

Reply to ‘Comment on ‘Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system”
por: Bae, Jeong Mo, et al.
Publicado: (2018)

Intrahepatic cholangiocarcinomas with IDH1/2 mutation-associated hypermethylation at selective genes and their clinicopathological features
por: Lee, Kyoungbun, et al.
Publicado: (2020)

Association of pathway mutation with survival after recurrence in colorectal cancer patients treated with adjuvant fluoropyrimidine and oxaliplatin chemotherapy
por: Lee, Dae-Won, et al.
Publicado: (2019)

The CpG island methylator phenotype may confer a survival benefit in patients with stage II or III colorectal carcinomas receiving fluoropyrimidine-based adjuvant chemotherapy
por: Min, Byung-Hoon, et al.
Publicado: (2011)

Synchronous mucosal Schwann-cell hamartomas in a young adult suggestive of mucosal Schwann-cell harmatomatosis: a case report
por: Bae, Jeong Mo, et al.
Publicado: (2015)

Different prognostic effect of CpG island methylation according to sex in colorectal cancer patients treated with adjuvant FOLFOX
por: Lee, Dae-Won, et al.
Publicado: (2015)

Standardized Pathology Report for Colorectal Cancer, 2nd Edition
por: Kim, Baek-hui, et al.
Publicado: (2020)

Variation of the seed endophytic bacteria among plant populations and their plant growth‐promoting activities in a wild mustard plant species, Capsella bursa‐pastoris
por: Choi, Byungwook, et al.
Publicado: (2022)

Adverse prognostic impact of the CpG island methylator phenotype in metastatic colorectal cancer
por: Cha, Yongjun, et al.
Publicado: (2016)

Tumor Control and Overall Survival after Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Colorectal Cancer: A Meta-Analysis
por: Choi, Hoon Sik, et al.
Publicado: (2020)

Risk factors and factors affecting the severity of overactive bladder symptoms in Korean women who use public health centers
por: Chae, Jungsoo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bt3ek9o8mrbebgrt1v039v6j8o